Supplementary Figure 1 from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction | Synapse
September 16, 2024
Supplementary Figure 1 from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure 1. Genomic profiles of the validation cohort.